Abstract:Background and Objectives Solid organ transplant surgeries including liver transplants constitute a substantial risk of bleeding complications and given frequent national blood shortages, supporting D‐negative transplant recipients with D‐negative red blood cell products perioperatively can be difficult for the transfusion services. This study was designed to compare the incidence of alloimmunization after D‐mismatched red cell transfusions between patients with and without a history of solid organ transplant at a single tertiary care hospital. The patients undergoing solid organ transplants are on strong immunosuppressive regimens perioperatively to help reduce the risk of rejection. We hypothesized that the use of these immunosuppressive agents makes these patients very less likely to mount an immune response and form anti‐D antibodies when exposed to the D‐positive red blood cell products perioperatively. Study Design and Methods At our center, D‐negative patients who received ≥1 unit of D‐positive red blood cell products were identified using historical transfusion records. Antibody testing results were examined to determine the incidence of the formation of anti‐D and any other red cell alloantibodies after transfusion and these results were compared between patients with and without a history of solid organ transplant. Results We were able to identify a total of 22 patients over 10 years with D‐negative phenotype who had undergone a solid organ transplant and had received D‐positive red blood cell products during the transplant surgeries. We also identified a second group of 54 patients with D‐negative phenotype who had received D‐positive red blood cell products for other indications including medical and surgical. A comparison of the data showed no new anti‐D formation among patients with a history of D mismatched transfusion during solid organ transplant surgeries. Conclusion Among our limited study population, we observed a very low likelihood of D alloimmunization among solid organ transplant recipients. A larger, prospective study could help further evaluate the need for prophylactic D matching for red cell transfusions during solid organ transplant surgeries.

Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis

Anti‐D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta‐analysis

Incidence of formation of anti‐D between patients with and without a history of solid organ transplant

Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD negative concentrates during 5 years

Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

Prospective Evaluation of A Transfusion Policy of Rhd-Positive Red Blood Cells into Del Patients in China

Naturally Occurring Anti-D in a Male Blood Donor, Unresolved Mystery

RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic

Secondary Alloanti-D Immunization Post Transfusion of “asia Type” DEL Red Blood Cells

RhD‐negative red blood cells can be saved during liver transplantation in RhD‐negative patients due to low risk of alloimmunization against RhD

Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion

Another piece of the hemolytic disease of the fetus and newborn puzzle after RhD-positive transfusion in trauma resuscitation: the proportion of pregnant women who produce high titer anti-D

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Impact of Alloantibody Strength in Crossmatch Negative DSA Positive Kidney Transplantation

Patients with Asian-type DEL Can Safely Be Transfused with RhD-positive Blood.

Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D

'Old is gold' does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India

Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients

Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?

Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma